(Bloomberg) -- CVS Caremark Corp. sold $5.5 billion
of debt in the second-biggest corporate bond sale of the year,
according to data compiled by Bloomberg. The yields were at or
below what the company's bankers first proposed.
The second-largest U.S. drugstore chain split the offering
between $1.75 billion of notes due in 2010 that float at 30 basis
points more than the three-month London interbank offered rate;
$1.75 billion of 5.75 percent securities due in 2017; $1 billion
of 6.25 percent bonds due in 2027; and $1 billion of so-called
hybrid bonds due in 2062.
Read more at Bloomberg Bonds News
of debt in the second-biggest corporate bond sale of the year,
according to data compiled by Bloomberg. The yields were at or
below what the company's bankers first proposed.
The second-largest U.S. drugstore chain split the offering
between $1.75 billion of notes due in 2010 that float at 30 basis
points more than the three-month London interbank offered rate;
$1.75 billion of 5.75 percent securities due in 2017; $1 billion
of 6.25 percent bonds due in 2027; and $1 billion of so-called
hybrid bonds due in 2062.
Read more at Bloomberg Bonds News
No comments:
Post a Comment